• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体重指数与重度哮喘急性加重成人患者急诊科治疗反应的前瞻性队列研究。

Body mass index and response to emergency department treatment in adults with severe asthma exacerbations: a prospective cohort study.

作者信息

Rodrigo Gustavo J, Plaza Vicente

机构信息

Departamento de Emergencia, Hospital Central de las FF.AA, Av. 8 de Octubre 3020, Montevideo 11600, Uruguay.

出版信息

Chest. 2007 Nov;132(5):1513-9. doi: 10.1378/chest.07-0936. Epub 2007 Sep 21.

DOI:10.1378/chest.07-0936
PMID:17890469
Abstract

BACKGROUND

In acute asthma (AA), overweight/obesity (body mass index [BMI]>or=25 kg/m2) have been related to poorer outcomes and higher risk of complications.

METHODS

We designed a prospective cohort study to determine if overweight/obese adults with severe episodes of AA require longer duration of emergency department (ED) treatment and have higher hospitalization rates compared with underweight/normal asthmatics (BMI<25 kg/m2). All patients received inhaled albuterol (maximum 6 h). Patients were discharged or admitted according to standard accepted criteria. The weight and height of each patient were measured during the ED stay.

RESULTS

Four hundred twenty-six patients (mean, 33.4+/-11.5 years [+/-SD]; 63% women) with severe exacerbations (FEV1, 28.2+/-11.9% of predicted) were enrolled. One hundred sixty-three patients (38.3%) were classified as overweight/obese. Patients with BMI>or=25 kg/m2 showed significant increases in length of ED stay (2.3 h vs 1.9 h, p=0.01) and rate of hospitalization (13.7% vs 6.8%, p=0.02), despite adjustments for other confounding variables. They also presented a higher rate of use of inhaled steroids and theophylline within the past 7 days. At the end of treatment, overweight/obese patients displayed more wheezing. Multivariate analysis demonstrated that BMI>or=25 kg/m2 resulted unrelated to final change in peak expiratory flow from baseline. By contrast, BMI>or=25 kg/m2 was related with duration of ED treatment (p=0.002).

CONCLUSIONS

Overweight/obese patients were admitted to the hospital more frequently than underweight/normal patients. This may reflect a difference in the perception of dyspnea, or it may reflect an underlying difference in asthma severity between the two groups.

摘要

背景

在急性哮喘(AA)中,超重/肥胖(体重指数[BMI]≥25kg/m²)与较差的预后及更高的并发症风险相关。

方法

我们设计了一项前瞻性队列研究,以确定与体重过轻/正常的哮喘患者(BMI<25kg/m²)相比,患有严重AA发作的超重/肥胖成年人是否需要更长时间的急诊科(ED)治疗以及具有更高的住院率。所有患者均接受吸入沙丁胺醇(最长6小时)治疗。患者根据公认的标准出院或入院。在患者于ED留观期间测量其体重和身高。

结果

纳入了426例严重加重(第1秒用力呼气容积[FEV₁]为预测值的28.2%±11.9%)的患者(平均年龄33.4±11.5岁[±标准差];63%为女性)。163例患者(38.3%)被分类为超重/肥胖。尽管对其他混杂变量进行了调整,但BMI≥25kg/m²的患者在ED的留观时间(2.3小时对1.9小时,p=0.01)和住院率(13.7%对6.8%,p=0.02)显著增加。他们在过去7天内吸入类固醇和茶碱的使用率也更高。治疗结束时,超重/肥胖患者喘息更多。多变量分析表明,BMI≥25kg/m²与呼气峰值流速相对于基线的最终变化无关。相比之下,BMI≥25kg/m²与ED治疗时间相关(p=约0.002)。

结论

超重/肥胖患者比体重过轻/正常患者更频繁地入院。这可能反映了对呼吸困难感知的差异,或者可能反映了两组之间哮喘严重程度的潜在差异。

相似文献

1
Body mass index and response to emergency department treatment in adults with severe asthma exacerbations: a prospective cohort study.体重指数与重度哮喘急性加重成人患者急诊科治疗反应的前瞻性队列研究。
Chest. 2007 Nov;132(5):1513-9. doi: 10.1378/chest.07-0936. Epub 2007 Sep 21.
2
Body mass index and asthma severity among adults presenting to the emergency department.前往急诊科就诊的成年人的体重指数与哮喘严重程度
Chest. 2003 Sep;124(3):795-802. doi: 10.1378/chest.124.3.795.
3
Body mass index and response to asthma therapy: fluticasone propionate/salmeterol versus montelukast.体重指数与哮喘治疗反应:丙酸氟替卡松/沙美特罗与孟鲁司特的比较
J Asthma. 2010 Feb;47(1):76-82. doi: 10.3109/02770900903338494.
4
Body mass index and acute asthma severity among children presenting to the emergency department.体质指数与儿童急诊急性哮喘严重程度的相关性。
Pediatr Allergy Immunol. 2010 May;21(3):480-8. doi: 10.1111/j.1399-3038.2009.00911.x. Epub 2009 Jun 22.
5
Body mass index and risk of hospitalization among adults presenting with asthma exacerbation to the emergency department.因哮喘急性加重到急诊科就诊的成年人的体重指数与住院风险
Ann Am Thorac Soc. 2014 Nov;11(9):1439-44. doi: 10.1513/AnnalsATS.201406-270BC.
6
Influence of body mass indexes on response to treatment in acute asthma.体重指数对急性哮喘治疗反应的影响。
Acta Med Iran. 2014;52(3):192-6.
7
Association of body mass index with increased cost of care and length of stay for emergency department patients with chest pain and dyspnea.体重指数与胸痛和呼吸困难的急诊科患者护理费用增加及住院时间的关联。
Circ Cardiovasc Qual Outcomes. 2014 Mar;7(2):292-8. doi: 10.1161/CIRCOUTCOMES.113.000702. Epub 2014 Mar 4.
8
Asthma severity, exacerbation risk, and controller treatment burden in underweight and obese children.体重不足和肥胖儿童的哮喘严重程度、急性加重风险及控制治疗负担
J Asthma. 2012 Jun;49(5):456-63. doi: 10.3109/02770903.2012.677895. Epub 2012 Apr 25.
9
What role does body mass index play in hospital admission rates from the pediatric emergency department?体重指数在儿科急诊科的住院率中起什么作用?
Pediatr Emerg Care. 2013 Sep;29(9):974-8. doi: 10.1097/PEC.0b013e3182a21a23.
10
Efficacy of nebulized fluticasone propionate in adult patients admitted to the emergency department due to bronchial asthma attack.雾化吸入丙酸氟替卡松对因支气管哮喘发作而入住急诊科的成年患者的疗效。
Isr Med Assoc J. 2008 Aug-Sep;10(8-9):568-71.

引用本文的文献

1
Exploring the association between asthma and chronic comorbidities: impact on clinical outcomes.探索哮喘与慢性共病之间的关联:对临床结局的影响。
Front Med (Lausanne). 2024 Jan 26;11:1305638. doi: 10.3389/fmed.2024.1305638. eCollection 2024.
2
Risk factors for SARS-CoV-2 infection and transmission in households with children with asthma and allergy: A prospective surveillance study.有哮喘和过敏儿童的家庭中 SARS-CoV-2 感染和传播的危险因素:一项前瞻性监测研究。
J Allergy Clin Immunol. 2022 Aug;150(2):302-311. doi: 10.1016/j.jaci.2022.05.014. Epub 2022 Jun 1.
3
Biomarkers for Overweight in Adult-Onset Asthma.
成人起病型哮喘超重的生物标志物
J Asthma Allergy. 2020 Oct 2;13:409-414. doi: 10.2147/JAA.S276371. eCollection 2020.
4
Asthma: New Integrative Treatment Strategies for the Next Decades.哮喘:未来几十年的新综合治疗策略。
Medicina (Kaunas). 2020 Aug 28;56(9):438. doi: 10.3390/medicina56090438.
5
Optimizing lifestyle interventions in adult patients with comorbid asthma and obesity.优化合并哮喘和肥胖的成年患者的生活方式干预措施。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620906323. doi: 10.1177/1753466620906323.
6
The Effects of Obesity in Asthma.肥胖对哮喘的影响。
Curr Allergy Asthma Rep. 2019 Sep 10;19(10):49. doi: 10.1007/s11882-019-0877-z.
7
Pharmacogenetic Factors Affecting Asthma Treatment Response. Potential Implications for Drug Therapy.影响哮喘治疗反应的药物遗传学因素。对药物治疗的潜在影响。
Front Pharmacol. 2019 May 21;10:520. doi: 10.3389/fphar.2019.00520. eCollection 2019.
8
Obesity and severe asthma.肥胖与重度哮喘。
Allergol Int. 2019 Apr;68(2):135-142. doi: 10.1016/j.alit.2018.10.004. Epub 2018 Dec 1.
9
Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults.北欧关于成人可能的重度哮喘系统评估与管理的共识声明。
Eur Clin Respir J. 2018 Mar 6;5(1):1440868. doi: 10.1080/20018525.2018.1440868. eCollection 2018.
10
Association Between Obesity and Acute Severity Among Patients Hospitalized for Asthma Exacerbation.肥胖与哮喘加重住院患者急性严重程度的关系。
J Allergy Clin Immunol Pract. 2018 Nov-Dec;6(6):1936-1941.e4. doi: 10.1016/j.jaip.2018.02.001. Epub 2018 Feb 14.